Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000668677 | SCV000793317 | likely pathogenic | Peroxisome biogenesis disorder type 3B; Peroxisome biogenesis disorder 3A (Zellweger) | 2017-08-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001385892 | SCV001585908 | pathogenic | Peroxisome biogenesis disorder 3A (Zellweger) | 2020-07-26 | criteria provided, single submitter | clinical testing | This sequence change results in a premature translational stop signal in the PEX12 gene (p.Asp262Thrfs*15). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 98 amino acids of the PEX12 protein. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with PEX12-related conditions. ClinVar contains an entry for this variant (Variation ID: 553270). This variant disrupts the C-terminus of the PEX12 protein. Other variant(s) that disrupt this region (p.Cys307Serfs*2) have been determined to be pathogenic (Invitae). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic. |